Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-09

Clinical Trial Update: FIGHT-RP 1 Extension Study [Phase 1]

View source ↗

Summary

The FIGHT-RP 1 extension study for retinitis pigmentosa is a Phase 1 trial sponsored by Johns Hopkins University and is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Retinitis Pigmentosa | Phase 1 | Status: ACTIVE_NOT_RECRUITING